Narrator: This is Science Today. Researchers at the Neuroscience Research Institute at the University of California , Santa Barbara have discovered three molecules – from a search of up to 100 thousand compounds – that seem to inhibit one of the key perpetrators of Alzheimer's disease. Ken Kosik, co-director of the institute, says each of these three molecules protects a protein called ‘tau', which becomes hopelessly tangled up in the brains of Alzheimer's patients. Kosik adds that this discovery may lead to the development of new drugs for the disease.
Kosik: People often think about this kind of work as going on in a pharmaceutical industry. And indeed, the more common path over the past many decades has been for drug discovery to occur within the industry and not so much in academia as we have done. But that trend is rapidly changing, I think, for the better.
Narrator: Kosik adds that as the baby boomers age, the incidence of Alzheimer's Disease, which is already increasing, will rise much more. For Science Today, I'm Larissa Branin.